DAPDUNE HOUSE SURGERY — All Prescriptions & Medications — Page 7
Practice Code: H81029 | GUILDFORD, GU1 4RP
Showing results 301-350 of 572
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Powder extensively hydrolysed formula (0913101) | 59 | 126.0K | £3.9K | -18.1% ▼ |
| Methylprednisolone acetate | 59 | 79 | £260 | -48.9% ▼ |
| 59 | 226 | £907 | +90.2% ▲ | |
| Buspirone hydrochloride | 58 | 512 | £76 | +15.1% ▲ |
| Metronidazole | 57 | 971 | £133 | -13.3% ▼ |
| Levonorgestrel | 56 | 59 | £4.7K | +48.4% ▲ |
| Leflunomide | 55 | 2,910 | £615 | +45.3% ▲ |
| Colchicine | 55 | 2,774 | £54 | -29.5% ▼ |
| Betamethasone sodium phosphate | 55 | 650 | £144 | +112.3% ▲ |
| 54 | 600 | £2.0K | +75.7% ▲ | |
| Nortriptyline | 53 | 5,992 | £236 | -63.6% ▼ |
| Dexamfetamine sulfate | 53 | 3,170 | £3.1K | +47.4% ▲ |
| 53 | 13.5K | £684 | -47.8% ▼ | |
| Ranolazine | 52 | 2,688 | £484 | -69.4% ▼ |
| Etoricoxib | 52 | 1,932 | £439 | -35.5% ▼ |
| Brimonidine tartrate | 52 | 505 | £384 | +30.2% ▲ |
| 52 | 168 | £1.1K | +86.9% ▲ | |
| Urea | 51 | 20.2K | £843 | -23.7% ▼ |
| Light liquid paraffin | 51 | 23.5K | £477 | +49.8% ▲ |
| Metoprolol tartrate | 50 | 5,040 | £1.9K | -1.4% vs avg |
| Umeclidinium bromide/vilanterol | 49 | 72 | £2.2K | -74.9% ▼ |
| Duloxetine hydrochloride | 49 | 3,154 | £656 | -4.4% ▼ |
| Mefenamic acid | 49 | 3,052 | £603 | +8.5% ▲ |
| Coal tar | 49 | 11.3K | £272 | -32.7% ▼ |
| 49 | 50 | £115 | +51.2% ▲ | |
| Glycerol | 48 | 996 | £152 | +36.8% ▲ |
| Medroxyprogesterone acetate | 48 | 2,256 | £462 | +25.4% ▲ |
| Fluticasone propionate (Nasal) | 48 | 96 | £623 | -67.0% ▼ |
| Clobazam | 47 | 1,298 | £148 | -28.7% ▼ |
| Diphtheria | 47 | 47 | £340 | -29.6% ▼ |
| 46 | 297 | £727 | +90.3% ▲ | |
| Ursodeoxycholic acid | 45 | 8,780 | £1.3K | -32.0% ▼ |
| Colesevelam hydrochloride | 44 | 9,900 | £4.3K | +16.0% ▲ |
| Terbutaline sulphate | 44 | 754 | £667 | -18.9% ▼ |
| Erythromycin | 44 | 4,788 | £1.9K | +27.0% ▲ |
| Celecoxib | 44 | 2,936 | £141 | -33.4% ▼ |
| 44 | 3,908 | £365 | -66.4% ▼ | |
| 44 | 24.5K | £176 | -51.7% ▼ | |
| Trazodone hydrochloride | 43 | 1,708 | £75 | -79.0% ▼ |
| Orlistat | 43 | 4,158 | £1.0K | -47.8% ▼ |
| Pramipexole | 43 | 3,218 | £2.5K | -56.2% ▼ |
| Glucose | 43 | 4,880 | £439 | -17.3% ▼ |
| Domperidone | 42 | 10.3K | £2.2K | +17.8% ▲ |
| Phenytoin sodium | 42 | 4,704 | £614 | -48.0% ▼ |
| Fosfomycin trometamol | 42 | 53 | £245 | +47.6% ▲ |
| 42 | 1,261 | £339 | -15.0% ▼ | |
| Denosumab | 41 | 41 | £7.5K | +50.7% ▲ |
| Nicorandil | 40 | 1,160 | £137 | -72.2% ▼ |
| Ondansetron hydrochloride | 40 | 1,893 | £700 | -17.6% ▼ |
| Verapamil hydrochloride | 39 | 2,968 | £366 | -57.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.